Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports US$ 25.55 Min. order: 1 piece ★★★★★ 4.3 (42 reviews) Sold : Login>>
Mazdutide and Tirzepatide: How These Dual-Pathway Weight-Loss Drugs Really Compare US$ 23.39 Min. order: 1 piece ★★★★★ 4.4 (28 reviews) Sold : Login>>
GLP-1-based therapies for diabetes, obesity and beyond US$ 24.60 Min. order: 1 piece ★★★★★ 4.3 (99 reviews) Sold : Login>>
Incretin-based therapies for the treatment of obesity-related diseases US$ 25.78 Min. order: 1 piece ★★★★★ 4.0 (141 reviews) Sold : Login>>
Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review US$ 29.10 Min. order: 1 piece ★★★★★ 4.9 (298 reviews) Sold : Login>>